Comparison of MEOPA + Paracetamol Versus Morphine Treatment in Acute Coronary Syndrome Analgesia.

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 680 participants.

Also called NCT02198378

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 680 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02198378
Other papers using this trial's data
  • Nitrous oxide/oxygen plus acetaminophen versus morphine in ST elevation myocardial infarction: open-label, cluster-randomized, non-inferiority study Scandinavian journal of trauma, resuscitation and emergency medicine, 2020-05-12 DOI, PubMed 32398160, PMC7218609 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France, Réunion (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02198378. Randomized; no masking; primary purpose treatment. Start 2014-11 (actual); primary completion 2017-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of MEOPA + Paracetamol Versus Morphine Treatment in Acute Coronary Syndrome Analgesia.
Acronym
SCADOLII
Condition
Acute Coronary Syndrome
Intervention (Drug)
MEOPA and paracetamol
Intervention (Drug)
Morphine
Lead sponsor
University Hospital, Toulouse (class: other)

Record details

Record id
cardio:ct-nct02198378
Content hash
c0545955c8bd89f54bd926134538c07bc7548cdd69308ba548650be2b66db031